Cargando…

(S)-N-[1-(5-Benzyl­sulfan­yl-1,3,4-oxa­diazol-2-yl)-2-phenyl­eth­yl]-4-methyl­benzene­sulfonamide

The title compound, C(24)H(23)N(3)O(3)S(2), crystallizes with two independent mol­ecules in the asymmetric unit. They differ essentially in the orientation of the tolyl rings, between which there is π–π stacking (centroid–centroid distance = 3.01 Å). The absolute configuration was confirmed by the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed, Tayyaba, Hameed, Shahid, Jones, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247610/
https://www.ncbi.nlm.nih.gov/pubmed/22219915
http://dx.doi.org/10.1107/S1600536811040669
_version_ 1782220146569379840
author Syed, Tayyaba
Hameed, Shahid
Jones, Peter G.
author_facet Syed, Tayyaba
Hameed, Shahid
Jones, Peter G.
author_sort Syed, Tayyaba
collection PubMed
description The title compound, C(24)H(23)N(3)O(3)S(2), crystallizes with two independent mol­ecules in the asymmetric unit. They differ essentially in the orientation of the tolyl rings, between which there is π–π stacking (centroid–centroid distance = 3.01 Å). The absolute configuration was confirmed by the determination of the Flack parameter [x = 0.008 (9)]. In the crystal, mol­ecules are connected by two classical N—H⋯N hydrogen bonds and two weak but very short C—H⋯O(sulfon­yl) inter­actions, forming layers lying parallel to the bc plane.
format Online
Article
Text
id pubmed-3247610
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-32476102012-01-04 (S)-N-[1-(5-Benzyl­sulfan­yl-1,3,4-oxa­diazol-2-yl)-2-phenyl­eth­yl]-4-methyl­benzene­sulfonamide Syed, Tayyaba Hameed, Shahid Jones, Peter G. Acta Crystallogr Sect E Struct Rep Online Organic Papers The title compound, C(24)H(23)N(3)O(3)S(2), crystallizes with two independent mol­ecules in the asymmetric unit. They differ essentially in the orientation of the tolyl rings, between which there is π–π stacking (centroid–centroid distance = 3.01 Å). The absolute configuration was confirmed by the determination of the Flack parameter [x = 0.008 (9)]. In the crystal, mol­ecules are connected by two classical N—H⋯N hydrogen bonds and two weak but very short C—H⋯O(sulfon­yl) inter­actions, forming layers lying parallel to the bc plane. International Union of Crystallography 2011-10-08 /pmc/articles/PMC3247610/ /pubmed/22219915 http://dx.doi.org/10.1107/S1600536811040669 Text en © Syed et al. 2011 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Syed, Tayyaba
Hameed, Shahid
Jones, Peter G.
(S)-N-[1-(5-Benzyl­sulfan­yl-1,3,4-oxa­diazol-2-yl)-2-phenyl­eth­yl]-4-methyl­benzene­sulfonamide
title (S)-N-[1-(5-Benzyl­sulfan­yl-1,3,4-oxa­diazol-2-yl)-2-phenyl­eth­yl]-4-methyl­benzene­sulfonamide
title_full (S)-N-[1-(5-Benzyl­sulfan­yl-1,3,4-oxa­diazol-2-yl)-2-phenyl­eth­yl]-4-methyl­benzene­sulfonamide
title_fullStr (S)-N-[1-(5-Benzyl­sulfan­yl-1,3,4-oxa­diazol-2-yl)-2-phenyl­eth­yl]-4-methyl­benzene­sulfonamide
title_full_unstemmed (S)-N-[1-(5-Benzyl­sulfan­yl-1,3,4-oxa­diazol-2-yl)-2-phenyl­eth­yl]-4-methyl­benzene­sulfonamide
title_short (S)-N-[1-(5-Benzyl­sulfan­yl-1,3,4-oxa­diazol-2-yl)-2-phenyl­eth­yl]-4-methyl­benzene­sulfonamide
title_sort (s)-n-[1-(5-benzyl­sulfan­yl-1,3,4-oxa­diazol-2-yl)-2-phenyl­eth­yl]-4-methyl­benzene­sulfonamide
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247610/
https://www.ncbi.nlm.nih.gov/pubmed/22219915
http://dx.doi.org/10.1107/S1600536811040669
work_keys_str_mv AT syedtayyaba sn15benzylsulfanyl134oxadiazol2yl2phenylethyl4methylbenzenesulfonamide
AT hameedshahid sn15benzylsulfanyl134oxadiazol2yl2phenylethyl4methylbenzenesulfonamide
AT jonespeterg sn15benzylsulfanyl134oxadiazol2yl2phenylethyl4methylbenzenesulfonamide